دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Preventing Post-Colonoscopy Colorectal Cancer in Inflammatory Bowel Disease—“The Big Five� Free
doi : 10.1093/ecco-jcc/jjae140
Volume 19, Issue 3, March 2025
Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease
doi : 10.1093/ecco-jcc/jjaf027
Letter: Change in Bowel Urgency in Active Ulcerative Colitis Patients Treated with Curcumin-QingDai (CurQD): A Post Hoc Analysis of a Randomized Placebo-Controlled Trial
doi : 10.1093/ecco-jcc/jjae147
Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae179
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel disease
doi : 10.1093/ecco-jcc/jjaf026
The ulcerative colitis risk gene adenylyl cyclase 7 restrains the T-helper 2 phenotype and Class II antigen presentation
doi : 10.1093/ecco-jcc/jjaf030
Uncovering the therapeutic potential of anti-tuberculoid agent Isoniazid in a model of microbial-driven Crohn’s disease Open Access
doi : 10.1093/ecco-jcc/jjaf032
Independent predictors of 90-day readmission in patients with inflammatory bowel disease: a nationwide retrospective study
doi : 10.1093/ecco-jcc/jjaf034
IL23R-Specific CAR Tregs for the Treatment of Crohn’s Disease Open Access
doi : 10.1093/ecco-jcc/jjae135
The Impact of Group Cognitive Behavioral Psychotherapy on Disease Severity and Psychosocial Functioning in Patients With Inflammatory Bowel Disease: A Randomized Controlled Study
doi : 10.1093/ecco-jcc/jjae144
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-Treat Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae145
Prolonged Time to Diagnosis of Crohn’s Disease in Patients With Perianal Fistulas Negatively Affects Long-Term Outcomes Open Access
doi : 10.1093/ecco-jcc/jjae146
Oxidized Polyunsaturated Fatty Acid Promotes Colitis and Colitis-Associated Tumorigenesis in Mice
doi : 10.1093/ecco-jcc/jjae148
Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect in Ulcerative Colitis: Analyses of the ELEVATE UC Clinical Program Open Access
doi : 10.1093/ecco-jcc/jjae150
Outcomes of Patients With Prior Biologic Intolerance Are Better Than Those With Biologic Failure in Clinical Trials of Inflammatory Bowel Disease Open Access
doi : 10.1093/ecco-jcc/jjae151
Cancer Characteristics, Prognoses, and Mortality of Colorectal Cancer in Patients With Crohn’s Disease—A Danish Nationwide Cohort Study, 2009-2019
doi : 10.1093/ecco-jcc/jjae153
The Intestinal Mucin Isoform Landscape Reveals Region-Specific Biomarker Panels for Inflammatory Bowel Disease Patient Stratification Open Access
doi : 10.1093/ecco-jcc/jjae155
The Circulating Methylome in Childhood-Onset Inflammatory Bowel Disease Open Access
doi : 10.1093/ecco-jcc/jjae157
Mucosal Cytokine Expression Associated With Deep Endoscopic Mucosal Healing in Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjae158
Crohn’s Disease and Ulcerative Colitis Share 2 Molecular Subtypes With Different Mechanisms and Drug Responses
doi : 10.1093/ecco-jcc/jjae152
Corrigendum: Darvadstrocel for Complex Perianal Fistulas in Japanese Adults with Crohn’s Disease: A Phase 3 Study Open Access
doi : 10.1093/ecco-jcc/jjae149
Correction to: P0722 Efficacy and Safety of Risankizumab in Patients With Moderate to Severe Crohn’s Disease: Results From the One-Year SEQUENCE Open-Label Long-Term Extension Free
doi : 10.1093/ecco-jcc/jjaf045
